topotecan has been researched along with coumarin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Arabshahi, HJ; Dyrkheeva, NS; Lavrik, OI; Mamontova, EM; Reynisson, J; Salakhutdinov, NF; Volcho, KP; Zakharenko, AL; Zakharova, OD | 1 |
2 other study(ies) available for topotecan and coumarin
Article | Year |
---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Identification of novel inhibitors for the tyrosyl-DNA-phosphodiesterase 1 (Tdp1) mutant SCAN1 using virtual screening.
Topics: Antineoplastic Agents; Binding Sites; Cell Line; Cell Survival; Coumarins; Drug Design; Drug Synergism; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Ligands; Molecular Docking Simulation; Mutation; Phosphoric Diester Hydrolases; Protein Structure, Tertiary; Topotecan | 2020 |